MedTrace Logo

Multiple Myeloma t(4 ;14) FFPE Samples

NCT07482761 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-03-19

No results posted yet for this study

Summary

This observational study aims to evaluate the feasibility of assembling a retrospective cohort of formalin-fixed paraffin-embedded (FFPE) tissue samples from patients with 4;14 translocated multiple myeloma, together with their associated clinical and pathological data. The study will determine whether these archived samples are suitable for exploratory biomarker assessment.

No intervention is performed. All FFPE samples and clinical data originate exclusively from routine diagnostic procedures and will be analyzed retrospectively for research purposes.

Conditions

  • Multiple Myeloma and Malignant Plasma Cell Neoplasms

Sponsors & Collaborators

  • BIWAKO

    lead INDUSTRY

Principal Investigators

  • Heba RASHED · MEDARKCRO

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-05
Primary Completion
2026-12-31
Completion
2027-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07482761 on ClinicalTrials.gov